A portable medicament case that includes a medicament provided in a package, and first and second housing members that are configured to form a medicament package receiving cavity when joined together. Each housing member including a mating member that is configured for engagement with the other housing member in order to join the first and second housing members together in a sealed configuration that prevents moisture or contaminants from entering into the cavity. Also, a magazine containing a plurality of medicament cases for administration of medicaments to a group of people, and a method of administering medications to mass casualties of multiple persons that are in need thereof. The medicaments are rapidly disintegratable and can include a dye that stains the person's mouth so that medical personnel can determine who has been treated with the medicament.

Aspects and embodiments of the present invention generally include a device for patient self-administration of a prescribed medication. The total quantity of doses to be contained in the device, the quantity of prescribed medication comprising each individual dose, and the dosing schedule, collectively referred to as prescription parameters, are determined and controlled solely by a health care provider (HCP) such as the patient's physician. In accordance with a prescribed dosing schedule, the device makes available for administration the precise quantity of prescribed medication constituting an individual dose. Patient access to the medication as well as patient control of the device is limited solely to the aspects of the device necessary to administer the available dose; that is, the patient has no control over the prescription parameters utilized by the device; that is, the quantity of a dose, the availability of individual doses, the schedule at which the doses are made available to the patient, nor the prescribed medication itself which is contained in the device. Preferably, the device also has a monitored subassembly which detects and transmits relevant device information to a remote management system accessible to the HCP, including detected attempts to alter, access, control or otherwise tamper with the device beyond its prescribed use. Advantageously, HCPs may render sufficient oversight and control over the device and its use to mitigate the risks associated with patients self-administering potentially dangerous or abusable medication without direct, in-person supervision.

A pill container having removable tabs, a cap, and a magnifying lens is described. The cap can rotatably fit and lock with the housing of the pill container. The housing is a hollow cylinder that includes a flange having breakable tabs where each tab is labeled with an hour of administration (HOA) that identifies the time at which the medications are to be taken. The breakable tabs include perforations around them to allow for the breaking. The cap of the pill container contains a magnifying lens that allows its user to use by removing the cap and using it to view the label, the contents of the pill container, and other writings and items in an enlarged manner. The cap includes retention features that allow the insertion and removal of the magnifying lens. The magnifying lens can be replaced with another lens that matches their eyeglass prescription.

The application describes a device for providing a medicament includes a dispensing compartment, a medicament storage compartment adapted to store a medicament packaging containing the medicament, a transport mechanism adapted to transport the medicament packaging containing the medicament from the medicament storage compartment to the dispensing compartment, an opening station disposed within the dispensing compartment and adapted to open the medicament packaging containing the medicament while on the transport mechanism, an extruder disposed within the dispensing compartment and adapted to remove the medicament from the medicament packaging, and an outlet from which a user can receive the medicament. The device may provide medicament at a desired scheduled interval. The device may be adapted to open a medicament packaging and remove a medicament from the medicament packaging.

Pump cassettes, wound-treatment apparatuses and methods. In some embodiments, a pump cassette comprises: a pump body having a pump chamber, an inlet valve in fluid communication with the pump chamber, and an outlet valve in fluid communication with the pump chamber; a diaphragm coupled to the pump body such that the diaphragm is movable to vary a volume in the pump chamber; and an identifier configured to store one or more properties of the pump cassette such that the identifier is readable by an automated reader to determine the one or more properties. In some embodiments, the pump cassette is configured to be removably coupled to a wound-treatment apparatus having an actuator such that the actuator can be activated to move the diaphragm.

A method of dispensing medication including: filling a medication container with one or more medication dose, using one or more actuator of a medication dispenser device, according to a prescription for a specific patient, where the prescription is stored in a patient record for the specific patient; verifying delivery of the medication container to a vicinity of the specific patient and/or an environment of the specific patient, where the verifying includes generating a delivery verification signal; verifying use of the one or more medication dose, where the verifying includes generating a use verification signal; and where one or both of the use verification signal and the delivery verification signal are generated using and/or interacting with the medication container.

A medical component is provided which includes a first portion formed of a first elastomeric material having at least one taggant embedded or incorporated therein, and a second portion formed of a second elastomeric material. The at least one taggant has a first diffusivity relative to the first elastomeric material and a second diffusivity relative to the second elastomeric material. The second diffusivity is less than the first diffusivity.

A packaging container for a drug having a recording medium and/or an identification mark for recording and updating one or more arbitrary information(s) selected from the group consisting of the information: an active ingredient of a drug, usage of a drug, drug dose, date of manufacture of a drug, expiration date of a drug, drug shipping date of a drug, traceability of drug delivery route from manufacturing to usage of a drug, and storage conditions (e.g., temperature, light (dark/light), humidity, etc.) including storage temperature and changes thereof, information including the administration date of a drug and a breakdown of the administration, amount of drug presented in drug-enclosing portion.

A method and verification system for verifying pharmaceuticals packaged within a pouch using a pharmacy packaging system. The method includes activating a first light source to illuminate the pharmaceutical pouch, capturing a first image of the pharmaceutical pouch while illuminated by the first light source, activating a second light source to illuminate the pharmaceutical pouch, and capturing a second image of the pharmaceutical pouch while illuminated by the second light source. The method further includes generating a third image based on the first image and the second image, generating a dashboard to simultaneously display first images, second images, and third images from a plurality of pharmaceutical pouches, providing a number of pills indication of a number of pills detected in the pouch against a number of pills expected in the pouch, and displaying the dashboard.

Aspects and embodiments of the present invention generally include a device for patient self-administration of a prescribed medication. The total quantity of doses to be contained in the device, the quantity of prescribed medication comprising each individual dose, and the dosing schedule, collectively referred to as prescription parameters, are determined and controlled solely by a health care provider (HCP) such as the patient's physician. In accordance with a prescribed dosing schedule, the device makes available for administration the precise quantity of prescribed medication constituting an individual dose. Patient access to the medication as well as patient control of the device is limited solely to the aspects of the device necessary to administer the available dose; that is, the patient has no control over the prescription parameters utilized by the device; that is, the quantity of a dose, the availability of individual doses, the schedule at which the doses are made available to the patient, nor the prescribed medication itself which is contained in the device. Preferably, the device also has a monitored subassembly which detects and transmits relevant device information to a remote management system accessible to the HCP, including detected attempts to alter, access, control or otherwise tamper with the device beyond its prescribed use. Advantageously, HCPs may render sufficient oversight and control over the device and its use to mitigate the risks associated with patients self-administering potentially dangerous or abusable medication without direct, in-person supervision.